The method of treating benign prostatic hyperplasia comprises trans-perineally introducing at least one energy delivery device through a perineal area of the patient in a first position in a prostate of the patient. Once the energy delivery device has been introduced, energy is delivered through the delivery device to a volume of tissue of the prostate, until the volume is vaporized or sublimated and a cavity is formed in the prostate tissue. The energy delivery device can then be removed from the prostate. Vaporization of adenomatous tissue provides immediate relieve of the urethra compression.
